Samuel Bates Martin - SVP AND CFO at Celldex Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Svp And Cfo
Issuer Symbol
CLDX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Samuel Bates Martin since 20 Jan 2025

Holdings reported by Samuel Bates Martin for Celldex Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 32,942 $341,937 $10.38 02 Jan 2026 Direct
Incentive Stock Option (Right to Buy) 58,815 02 Jan 2026 Direct Common Stock

Transactions reported by Samuel Bates Martin for Celldex Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.